Feyza Gündüz

437 citations
27 papers · 284 indexed · h-index 11
Topics
Liver Disease Diagnosis and Treatment (13 papers)Hepatitis C virus research (9 papers)Hepatocellular Carcinoma Treatment and Prognosis (8 papers)

In The Last Decade

Feyza Gündüz

24 papers receiving 279 citations

Peers

Feyza Gündüz
Comparison fields: 5 of 62
  • Epidemiology 138
  • Hepatology 113
  • Immunology 64
  • Molecular Biology 56
  • Genetics 37
Replace Yiran Wei with:
Yiran Wei China
Yukihisa Fujinaga Japan
Kazuya Okushin Japan
Hong-Di Ma China
Christoph Antoni Germany
Tamás Tornai Hungary
Valle Cadahía Spain
Serag Esmat Egypt
Dorothy Ndagire Uganda
Carl Janssen Belgium
Feyza Gündüz relative to Yiran Wei China Yiran Wei's profile →
Citations per field
00.5×6.5×
Yiran Wei · 1×
Citations per year

Countries citing papers authored by Feyza Gündüz

Since Specialization
Citations

This map shows the geographic impact of Feyza Gündüz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feyza Gündüz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feyza Gündüz more than expected).

Fields of papers citing papers by Feyza Gündüz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feyza Gündüz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feyza Gündüz. The network helps show where Feyza Gündüz may publish in the future.

Co-authorship network of co-authors of Feyza Gündüz

This figure shows the co-authorship network connecting the top 25 collaborators of Feyza Gündüz. A scholar is included among the top collaborators of Feyza Gündüz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feyza Gündüz. Feyza Gündüz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 10
4 4
5 2
6 5
7 13
8 29
9
The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in chronic HBV patients
1
10 28
11 4
12 45
13 14
14 12
15 13
16 9
17 16
18 24
19 19
20 3

About Feyza Gündüz

Feyza Gündüz is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 27 papers that have together received 284 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Hepatology (113 citations), Epidemiology (138 citations) and Immunology (64 citations). Feyza Gündüz has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Srikanta Dash, Sidhartha Hazari, Luis A. Balart, Partha K. Chandra, Coşkun Özer Demirtaş, Darren P. Baker, Güher Saruhan‐Direskeneli, Nefise Özlen Şahin, Yeşim Özen Alahdab and Veysel Tahan. Their work appears in journals such as PLoS ONE, Journal of Hepatology and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026